Our Biotech Portfolio Strategy
Fundamental analysis is the core of our strategy for selecting stocks and defining the proper weight in the portfolio.
We are investors not gamblers: when we believe in a company, we act as a partner of the project.
1. Idea Generation
Screening of medical research
Technological biotech platforms
Tracking skilful biotech people
2. Stock selection
3. Portfolio Allocation
Pre-trade risk analysis
Continuous assessment of portfolio robustness.
Required factors in Stock Analysis.
Very important to analyze the number and the quality of molecules under development. The potential market size is important too.
Essential to guarantee the future of the company.
Good Executive Management
Particular attention to Executive Management. Skillful people are the lifeblood for success.
Alliances with pharmaceutical companies or prestigious Universities are very important. The big pharmaceutical companies guarantee a constant flow of money. Universities give access to young researchers and new projects.
Sales growth is important to establish the right value of a company. We prefer to focus on revenues. Earnings are often depressed by temporary heavy investments.
In terms of duration, coverage and remaining time.